See What HealthDay Can Do For You
Contact Us

Omnaris Approved for Hay Fever

Nasal spray suppresses body's immune response

MONDAY, Oct. 23, 2006 (HealthDay News) -- Omnaris (ciclesonide) nasal spray has been approved by the U.S. Food and Drug Administration to treat symptoms of allergic rhinitis, commonly known as hay fever.

The drug, approved for adults and children 12 years and older, is a corticosteroid that suppresses the body's immune response to the allergens that trigger hay fever.

Some 35 million Americans have hay fever, making it the most common allergic condition, the FDA said. Symptoms include runny and itchy nose, sneezing, and nasal congestion.

During clinical testing, people who took Omnaris had up to a 10 percent reduction in nasal symptoms, compared with those who took a non-medicinal placebo. The most common side effects reported were headache, nosebleed, and nasal inflammation.

Omnaris is manufactured by Altana Pharma U.S., Inc.

More information

Visit the National Library of Medicine to learn more about hay fever.
Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.